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Fig. Association between chronic kidney disease (CKD) stage and
ﬂow-mediated vasodilation.
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70S Abstracts June Supplement 201453.9% for endoscopic (P < .001). After multivariate anal-
ysis, endoscopic vein harvest independently increased the
risk of 1-year primary patency loss compared with
continuous (hazard ratio, 1.38; 95% conﬁdence interval,
1.07-1.77; P ¼ .010). There was no signiﬁcant difference
in 1-year primary patency loss between skip and contin-
uous. Endoscopic vein harvest also increased the risk of
1-year primary patency loss compared with skip (hazard
ratio, 1.44; 95% conﬁdence interval, 1.11-1.87; P ¼
.006).
Conclusions: The choice of VHT had no impact on
surgical site infection rates in patients undergoing infrain-
guinal arterial bypass in the VQI population. Continuous
and skip incisions resulted in equivalent 1-year primary
patency, but the endoscopic VHT signiﬁcantly reduced
1-year primary patency.
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Objectives: Peripheral artery disease (PAD) and
chronic kidney disease (CKD) are both associated with
endothelial dysfunction. CKD may contribute to the pro-
gression of endothelial dysfunction in PAD patients. We
hypothesized that worsening renal function (RF) is associ-
ated with impaired endothelial function (EF) in patients
with PAD.
Methods: This was a cross-sectional study of PAD pa-
tients presenting to a vascular surgery clinic. Brachial artery
ﬂow-mediated vasodilation (FMD) was done to assess EF.
RF was determined by calculating estimated glomerular
ﬁltration rate (eGFR). Linear regression was performed
to assess the relationship between EF and RF in claudicant
patients.
Results: A total of 115 claudicant patients (97%
male) with eGFR $30 mL/min participated in this study.
Mean age was 69 6 8 years, and 77% were Caucasian.
Comorbidities included hypertension (90%), dyslipidemia
(83%), coronary artery disease (41%), and diabetes melli-
tus (36%). Mean ankle-brachial index (ABI) was 0.71 6
0.15 and mean FMD was 7.0% 6 3.8, indicating impaired
EF. As RF declined (P ¼ .001), EF decreased. After
multivariable regression adjusting for age, race, log tumor
necrosis factor-a, hypertension, dyslipidemia, and dia-
betes, only eGFR remained associated with EF (P ¼
.030).
Conclusions: In patients with PAD, worsening renal
function has a stronger association with endothelial
dysfunction than traditional cardiovascular risk factors do.
Further longitudinal studies are needed to explore whether
stabilization of renal function may decrease the risk of PAD
progression associated with endothelial dysfunction, as well
as the risk of major adverse cardiovascular events and
mortality.Author Disclosures: H. F. Alley: Nothing to disclose; K.
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Objectives: Despite increasing use of endovascular
techniques, lower limb surgical revascularization (LLSR)
is commonly performed with associated mortality risks.
Few studies have reported on robust outcome models
that accurately identify high-risk patients. This study
aimed to develop robust outcome models using data
from the United Kingdom National Vascular Database
(NVD).
Methods: Consecutive entries of LLSR into the
NVD (January 2008-October 2012) were analyzed for
demographics, comorbidity, symptoms, and type of inter-
vention. The primary outcome measure was in-hospital
mortality. Other outcome scores were calculated for com-
parison (FinnVasc, Prevent III, POSSUM). Multiple
imputation methodology was used to mitigate for missing
data. The dataset was divided nonchronologically into
model development (2/3) and validation (1/3) subsets.
Minimization of the Schwartz-Bayes criterion was used
to select preoperative variables and generate an optimal
logistic regression model to predict in-hospital mortality.
Model performance was assessed with receiver operating
characteristic (ROC) curve analysis. Hosmer-Lemeshow
analysis was used to assess calibration.
Results: A total of 17,980 operations were
analyzed. Overall in-hospital mortality was 2.9%. The
model generated, which used age, American Society of
Anesthesiologists grade, statin use, creatinine, white
cell count, albumin and heart rate, provided excellent
